2-5A Ligands—A New Concept for the Treatment of Prostate Cancer

REFERENCES

• Xiang , Y. , Wang , Z. , Murakami , J. , Plummer , S. , Klein , E. A. , Carpten , J. D. , Trent , J. M. , Isaacs , W. B. , Casey , G. and Silverman , R. H. 2003 . Effects of R Nase L mutations associated with prostate cancer on apoptosis induced by 2′,5′-oligoadenylates . Cancer Res. , 63 ( 20 ) : 6795 – 6801 .
   PubMed Web of Science ®Google Scholar
• Murphy , G. P. , Elgamal , A. A. , Su , S. L. , Bostwick , D. G. and Holmes , E. H. 1998 . Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen . Cancer , 83 ( 11 ) : 2259 – 2269 .
   PubMed Web of Science ®Google Scholar
• Israeli , R. S. , Powell , C. T. , Corr , J. G. , Fair , W. R. and Heston , W. D. 1994 . Expression of the prostate-specific membrane antigen . Cancer Res. , 54 ( 7 ) : 1807 – 1811 .
   PubMed Web of Science ®Google Scholar
• Wright , G. L. Jr. , Grob , B. M. , Haley , C. , Grossman , K. , Newhall , K. , Petrylak , D. , Troyer , J. , Konchuba , A. , Schellhammer , P. F. and Moriarty , R. 1996 . Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy . Urology , 48 ( 2 ) : 326 – 334 .
   PubMed Web of Science ®Google Scholar
• Liu , H. , Moy , P. , Kim , S. , Xia , Y. , Rajasekaran , A. , Navarro , V. , Knudsen , B. and Bander , N. H. 1997 . Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium . Cancer Res. , 57 ( 17 ) : 3629 – 3634 .
   PubMed Web of Science ®Google Scholar
• Chang , S. S. , Reuter , V. E. , Heston , W. D. , Bander , N. H. , Grauer , L. S. and Gaudin , P. B. 1999 . Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature . Cancer Res. , 59 ( 13 ) : 3192 – 3198 .
   PubMed Web of Science ®Google Scholar
• Chang , S. S. , O'Keefe , D. S. , Bacich , D. J. , Reuter , V. E. , Heston , W. D. and Gaudin , P. B. 1999 . Prostate-specific membrane antigen is produced in tumor-associated neovasculature . Clin. Cancer Res. , 5 ( 10 ) : 2674 – 2681 .
   PubMed Web of Science ®Google Scholar
• Dumas , F. , Gala , J. L. , Berteau , P. , Brasseur , F. , Eschwege , P. , Paradis , V. , Lacour , B. , Philippe , M. and Loric , S. 1999 . Molecular expression of PSMA mRNA and protein in primary renal tumors . Int. J. Cancer , 80 ( 6 ) : 799 – 803 .
   PubMed Web of Science ®Google Scholar
• Chang , S. S. , Reuter , V. E. , Heston , W. D. and Gaudin , P. B. 2001 . Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen . Urology , 57 ( 4 ) : 801 – 805 .
   PubMed Web of Science ®Google Scholar
• Silver , D. A. , Pellicer , I. , Fair , W. R. , Heston , W. D. and Cordon-Cardo , C. 1997 . Prostate-specific membrane antigen expression in normal and malignant human tissues . Clin. Cancer Res. , 3 ( 1 ) : 81 – 85 .
   PubMed Web of Science ®Google Scholar
• Troyer , J. K. , Beckett , M. L. and Wright , G. L. Jr. 1995 . Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids . Int. J. Cancer , 62 ( 5 ) : 552 – 558 .
   PubMed Web of Science ®Google Scholar
• Kozikowski , A. P. , Nan , F. , Conti , P. , Zhang , J. , Ramadan , E. , Bzdega , T. , Wroblewska , B. , Neale , J. H. , Pshenichkin , S. and Wroblewski , J. T. 2001 . Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase) . J. Med. Chem. , 44 ( 3 ) : 298 – 301 .
   PubMed Web of Science ®Google Scholar
• Jackson , P. F. , Tays , K. L. , Maclin , K. M. , Ko , Y. S. , Li , W. , Vitharana , D. , Tsukamoto , T. , Stoermer , D. , Lu , X. C. , Wozniak , K. and Slusher , B. S. 2001 . Design and pharmacological activity of phosphinic acid based NAALADase inhibitors . J. Med. Chem. , 44 ( 24 ) : 4170 – 4175 .
   PubMed Web of Science ®Google Scholar
• Tang , H. , Brown , M. , Ye , Y. , Huang , G. , Zhang , Y. , Wang , Y. , Zhai , H. , Chen , X. , Shen , T. Y. and Tenniswood , M. 2003 . Prostate targeting ligands based on N-acetylated alpha-linked acidic dipeptidase . Biochem. Biophys. Res. Commun. , 307 ( 1 ) : 8 – 14 .
   PubMed Web of Science ®Google Scholar
• Majer , P. , Jackson , P. F. , Delahanty , G. , Grella , B. S. , Ko , Y. S. , Li , W. , Liu , Q. , Maclin , K. M. , Polakova , J. , Shaffer , K. A. , Stoermer , D. , Vitharana , D. , Wang , E. Y. , Zakrzewski , A. , Rojas , C. , Slusher , B. S. , Wozniak , K. M. , Burak , E. , Limsakun , T. and Tsukamoto , T. 2003 . Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor . J. Med. Chem. , 46 ( 10 ) : 1989 – 1996 .
   PubMed Web of Science ®Google Scholar
• Rong , S. B. , Zhang , J. , Neale , J. H. , Wroblewski , J. T. , Wang , S. and Kozikowski , A. P. 2002 . Molecular modeling of the interactions of glutamate carboxypeptidase II with its potent NAAG-based inhibitors . J. Med. Chem. , 45 ( 19 ) : 4140 – 4152 .
   PubMed Web of Science ®Google Scholar
• Geselowitz , D. A. , Cramer , H. , Wondrak , E. M. , Player , M. R. and Torrence , P. F. 2000 . Fluorescence resonance energy transfer analysis of RNase L-catalyzed oligonucleotide cleavage . Antisense Nucleic Acid Drug Dev , 10 ( 1 ) : 45 – 51 .
   PubMedGoogle Scholar
• Imai , J. , Johnston , M. I. and Torrence , P. F. 1982 . Chemical modification potentiates the biological activities of 2-5A and its congeners . J. Biol. Chem. , 257 ( 21 ) : 12739 – 12745 .
   PubMed Web of Science ®Google Scholar
• Defilippi , P. , Huez , G. , Verhaegen-Lawalle , M. , De Clercq , E. , Imai , J. , Torrence , P. and Content , J. 1986 . Antiviral activity of a chemically stabilized 2-5A analog upon microinjection into HeLa cells . FEBS Lett. , 198 ( 2 ) : 326 – 332 .
   PubMed Web of Science ®Google Scholar
• Pomper , M. G. , Musachio , J. L. , Zhang , J. , Scheffel , U. , Zhou , Y. , Hilton , J. , Maini , A. , Dannals , R. F. , Wong , D. F. and Kozikowski , A. P. 2002 . 11C-MCG: synthesis, uptake selectivity, and primate PET of a probe for glutamate carboxypeptidase II (NAALADase) . Mol. Imaging , 1 ( 2 ) : 96 – 101 .
   PubMed Web of Science ®Google Scholar
• Heston , W. D. 1997 . Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase . Urology , 49 : 104 – 112 . (3A Suppl)
   PubMed Web of Science ®Google Scholar
• Pinto , J. T. , Suffoletto , B. P. , Berzin , T. M. , Qiao , C. H. , Lin , S. , Tong , W. P. , May , F. , Mukherjee , B. and Heston , W. D. 1996 . Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells . Clin. Cancer Res. , 2 ( 9 ) : 1445 – 1451 .
   PubMed Web of Science ®Google Scholar
• Bander , N. H. , Nanus , D. M. , Milowsky , M. I. , Kostakoglu , L. , Vallabahajosula , S. and Goldsmith , S. J. 2003 . Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen . Semin. Oncol. , 30 ( 5 ) : 667 – 676 .
   PubMed Web of Science ®Google Scholar
• Nanus , D. M. , Milowsky , M. I. , Kostakoglu , L. , Smith-Jones , P. M. , Vallabahajosula , S. , Goldsmith , S. J. and Bander , N. H. 2003 . Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen . J. Urol. , 170 : S84 – S88 . (6 Pt 2); discussion S88–S89
   PubMed Web of Science ®Google Scholar
• Bander , N. H. , Trabulsi , E. J. , Kostakoglu , L. , Yao , D. , Vallabhajosula , S. , Smith-Jones , P. , Joyce , M. A. , Milowsky , M. , Nanus , D. M. and Goldsmith , S. J. 2003 . Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen . J. Urol. , 170 ( 5 ) : 1717 – 1721 .
   PubMed Web of Science ®Google Scholar